Yamamoto Y - Search Results

1

Centrosome amplification as a putative prognostic biomarker for the classification of urothelial carcinomas.

Yamamoto Y, Misumi T, Eguchi S, Chochi Y, Kitahara S, Nakao M, Nagao K, Hara T, Sakano S, Furuya T, Oga A, Kawauchi S, Sasaki K, Matsuyama H. Yamamoto Y, et al. Hum Pathol. 2011 Dec;42(12):1923-30. doi: 10.1016/j.humpath.2011.02.013. Epub 2011 Jun 17. Hum Pathol. 2011. PMID: 21683985

2

Centrosome hyperamplification predicts progression and tumor recurrence in bladder cancer.

Yamamoto Y, Matsuyama H, Furuya T, Oga A, Yoshihiro S, Okuda M, Kawauchi S, Sasaki K, Naito K. Yamamoto Y, et al. Clin Cancer Res. 2004 Oct 1;10(19):6449-55. doi: 10.1158/1078-0432.CCR-04-0773. Clin Cancer Res. 2004. PMID: 15475431

3

Biological characteristics in bladder cancer depend on the type of genetic instability.

Yamamoto Y, Matsuyama H, Kawauchi S, Furuya T, Liu XP, Ikemoto K, Oga A, Naito K, Sasaki K. Yamamoto Y, et al. Clin Cancer Res. 2006 May 1;12(9):2752-8. doi: 10.1158/1078-0432.CCR-05-0805. Clin Cancer Res. 2006. PMID: 16675567

4

Overexpression of polo-like kinase 1 (PLK1) and chromosomal instability in bladder cancer.

Yamamoto Y, Matsuyama H, Kawauchi S, Matsumoto H, Nagao K, Ohmi C, Sakano S, Furuya T, Oga A, Naito K, Sasaki K. Yamamoto Y, et al. Oncology. 2006;70(3):231-7. doi: 10.1159/000094416. Epub 2006 Jul 6. Oncology. 2006. PMID: 16837776

5

Significance of cyclin E and p27 expression in malignant ovarian germ cell tumors: correlation with the cell proliferation activity and clinicopathologic features.

Kawauchi S, Yamamoto Y, Uchida K, Chochi Y, Kondo T, Oga A, Sasaki K. Kawauchi S, et al. Among authors: yamamoto y. Oncol Rep. 2006 Nov;16(5):1029-33. Oncol Rep. 2006. PMID: 17016588

6

Chromosome 20q13.2 gain may predict intravesical recurrence after nephroureterectomy in upper urinary tract urothelial tumors.

Akao J, Matsuyama H, Yamamoto Y, Sasaki K, Naito K. Akao J, et al. Among authors: yamamoto y. Clin Cancer Res. 2006 Dec 1;12(23):7004-8. doi: 10.1158/1078-0432.CCR-06-0825. Clin Cancer Res. 2006. PMID: 17145821

7

Gefitinib-related gene signature in bladder cancer cells identified by a cDNA microarray.

Inoue R, Matsuyama H, Yano S, Yamamoto Y, Iizuka N, Naito K. Inoue R, et al. Among authors: yamamoto y. Anticancer Res. 2006 Nov-Dec;26(6B):4195-202. Anticancer Res. 2006. PMID: 17201133 Free article.

8

Overexpression of BUBR1 is associated with chromosomal instability in bladder cancer.

Yamamoto Y, Matsuyama H, Chochi Y, Okuda M, Kawauchi S, Inoue R, Furuya T, Oga A, Naito K, Sasaki K. Yamamoto Y, et al. Cancer Genet Cytogenet. 2007 Apr 1;174(1):42-7. doi: 10.1016/j.cancergencyto.2006.11.012. Cancer Genet Cytogenet. 2007. PMID: 17350465

9

Association between DNA repair gene polymorphisms and p53 alterations in Japanese patients with muscle-invasive bladder cancer.

Sakano S, Matsumoto H, Yamamoto Y, Kawai Y, Eguchi S, Ohmi C, Matsuyama H, Naito K. Sakano S, et al. Among authors: yamamoto y. Pathobiology. 2006;73(6):295-303. doi: 10.1159/000099124. Pathobiology. 2006. PMID: 17374967

10

Gain of 5p15.33 is associated with progression of bladder cancer.

Yamamoto Y, Chochi Y, Matsuyama H, Eguchi S, Kawauchi S, Furuya T, Oga A, Kang JJ, Naito K, Sasaki K. Yamamoto Y, et al. Oncology. 2007;72(1-2):132-8. doi: 10.1159/000111132. Epub 2007 Nov 15. Oncology. 2007. PMID: 18025801

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,311 results

Search Page

Filters